4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-010683
Director sold 101,994 shares at an average $50.68 ($5,168,901)
- Director disposed of 592,918 shares (other)
- Director acquired 95,241 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woiwode Thomas Director | 2018-04-20 | Other disposition | −497,053 | 2,238,979 | I | ||
| Woiwode Thomas Director | 2018-04-20 | Other disposition | −2,947 | 13,277 | I | ||
| Woiwode Thomas Director | 2018-04-20 | Other acquisition | +92,918 | 92,918 | I | ||
| Woiwode Thomas Director | 2018-04-20 | Other disposition | −92,918 | 0 | I | ||
| Woiwode Thomas Director | 2018-04-20 | Other acquisition | +2,323 | 7,282 | D | ||
| Woiwode Thomas Director | 2018-04-23 | Sale | −89,628 | $50.66 | $4,540,554 | 1,539,576 | I |
| Woiwode Thomas Director | 2018-04-23 | Sale | −2,630 | $51.00 | $134,130 | 45,171 | I |
| Woiwode Thomas Director | 2018-04-23 | Sale | −2,915 | $51.00 | $148,665 | 50,072 | I |
| Woiwode Thomas Director | 2018-04-23 | Sale | −6,821 | $50.66 | $345,552 | 117,173 | I |
| Open-market sales · 101,994 sh · avg $50.68 · $5,168,901 | |||||||
Loading xslF345X03/doc4.xml…